Unlock instant, AI-driven research and patent intelligence for your innovation.

Chiral-specific boron-containing compounds and their use in the treatment of cancer or amyloidosis

A compound and composition technology, applied in the field of chiral specific boron-containing compounds, can solve problems such as instability

Active Publication Date: 2022-01-28
ARTIVILA BIOPHARMA
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

A major problem with such boronic acid compounds (active pharmaceutical ingredients, API) is that they are not very stable under usual environmental conditions such as drug Requires storage below ambient temperature and away from light, drug Formulated as an injection partly because of its instability, patients must go to the doctor's office or hospital to administer the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chiral-specific boron-containing compounds and their use in the treatment of cancer or amyloidosis
  • Chiral-specific boron-containing compounds and their use in the treatment of cancer or amyloidosis
  • Chiral-specific boron-containing compounds and their use in the treatment of cancer or amyloidosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0236] HL01-01 The product of Example 1, may be HL01-01-1, HL01-01-2, HL01-01-3, HL01-01-4, HL01-01-5 or mixtures thereof.

[0237]

Embodiment 2

[0238] HL01-02 embodiment of the product of Example 2, it may be HL01-02-1, HL-01-02-2, HL-01-02-3, HL-01-02-4 or mixtures thereof.

[0239]

Embodiment 15

[0240] The product of Example 15 HL01-17, may be HL01-17-1, HL01-17-2, HL01-17-3, HL-01-17-4, HL-1-17-5, or mixtures thereof.

[0241]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Useful chiral-specific boron-containing compounds, such as boronic esters, boraneamines, boranediamines, boraneamine thioesters, and boronic acid mono / dithiol esters, have been prepared, and compositions containing these compounds can be used in Anti-cancer or anti-amyloidosis disease.

Description

[0001] Cross-reference related application [0002] This application is based on US Provisional Patent June 19, 2015 filed equity No.62 / 181910, the entire contents of which are incorporated herein by reference. Technical field [0003] The present invention relates to boron-containing compound as a chiral specific anticancer or an anti-amyloid drug, such as boric acid, borate ester, amine boranes, borane-diamine, amine borane and borate thioesters mono / di thio esters, their composition, preparation and method of treatment. Background technique [0004] Some polypeptide containing boric acid as an inhibitor of proteasome plays a decisive role in the treatment of cancer, in addition to the drug commercially available (Bortezomib or [(lR) -3- methyl -1 - [[(2S) -1- phenyl-2-oxo-3 [(pyrazinylcarbonyl) amino] propyl] amino] butyl ] boronic acid) for the treatment of multiple myeloma, cancer and other types of amyloidosis diseases, there are many different structures in different ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/69A61K38/05
CPCC07K5/06191C07F5/022C07F5/025C07K5/06139C07K4/00A61K38/00
Inventor 韩国霞
Owner ARTIVILA BIOPHARMA